StockData
CVS HEALTH Corp logo

CVS HEALTH Corp

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3014% above fair value
$88.51−1.74 (-1.93%)

Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%

Cvs Health Pharmacy & Consumer Wellness Revenue by Line

Pharmacy & Consumer Wellness Revenue by Line — Other (MinuteClinic / Clinical) ($M)

QuarterlyAnnual

Cvs Health Pharmacy & Consumer Wellness Revenue by Line: $2,398M in FY2025, up 4.7% from a year earlier.

Latest, FY2025
2,398
Period ended Dec 31, 2025
Change on a year earlier
+4.7%
2,291 in FY2024
History
9 years
Since FY2017
Sources
7
Documents cited below

Where the FY2025 figure comes from

“|| Other | 2,398 | 2,291 | 2,199 | 107 | 4.7 | % | 92 | 4.2 | %”

Source: CVS Health 10-K (2026-02-10) ↗

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPharmacy & Consumer Wellness Revenue by Line — Other (MinuteClinic / Clinical) ($M)Year on yearSource
FY2025Dec 31, 20252,398+4.7%CVS Health 10-K (2026-02-10) ↗
FY2024Dec 31, 20242,291+4.2%CVS Health 10-K (2026-02-10) ↗
FY2023Dec 31, 20232,199-7.6%CVS Health 10-K (2026-02-10) ↗
FY2022Dec 31, 20222,380-0.9%CVS Health 10-K (2025-02-12) ↗
FY2021Dec 31, 20212,402+75.7%CVS Health 10-K (2024-02-07) ↗
FY2020Dec 31, 20201,367+83.7%CVS Health 10-K (2023-02-08) ↗
FY2019Dec 31, 2019744-1.5%CVS Health 10-K (2022-02-09) ↗
FY2018Dec 31, 2018755-31.4%CVS Health 10-K (2021-02-16) ↗
FY2017Dec 31, 20171,101–CVS Health 10-K (2020-02-18) ↗

Cite this data

StockData. (2026). Cvs Health Pharmacy & Consumer Wellness Revenue by Line ($M), annual FY2017–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/pcw-rev-other

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.